Skip to main content

Animations

MJFF Publications

5341 - 5350 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2016
  • 2023
  • 2016
  • 2023
  • 2022
  • 2017
  • 2022
  • 2018
  • 2023
  • Summary Details
    OPEN
    Title: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
    Journal Name: Pharmaceuticals
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ph16060883
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.08.023
    Citation Count: 14
  • Summary Details
    OPEN
    Title: RTP801 mediates transneuronal toxicity in culture via extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jev2.12378
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-161031
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Lack of significant Lewy pathology in 237 essential tremor brains
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/jnen/nlad022
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2022.05.002
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.021
    Citation Count: 103
  • Summary Details
    RESTRICTED
    Title: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Deep Brain Stimulation associated gliosis: A post-mortem study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.009
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-42813-8
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.